Rating Change
Leerink Partners reiterated its Outperform rating on Johnson & Johnson (NYSE:JNJ) on October 14, 2026.
reiterateNYSE:JNJ
Leerink Partners Reiterates Outperform Rating on Johnson & Johnson (JNJ)
Leerink Partners reiterated its Outperform rating on Johnson & Johnson (NYSE:JNJ) on October 14, 2026.
At publication ·
What changed
Johnson & Johnson (NYSE:JNJ) · reiterate
- Firm
- Leerink Partners
- Rating
- Outperform to Outperform
- Price at event
- $253.91
- Market capitalization
- $505.8B
At a glance
Key takeaways
- Leerink Partners reiterated an Outperform rating on Johnson & Johnson on October 14, 2026.
Market Context
Johnson & Johnson operates in the Healthcare sector. The stock currently trades at $253.91 with a market capitalization of $505.8B. The stock has gained 19.7% over the past 52 weeks.
Analyst coverage from Leerink Partners provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Johnson & Johnson.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Johnson & Johnson
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 14, 2026 | Leerink Partners | Outperform | N/A |
| Oct 14, 2026 | Wells Fargo | Overweight | N/A |
| Oct 14, 2026 | RBC Capital | Outperform | N/A |
| Oct 07, 2026 | Guggenheim | Buy | N/A |
| Oct 06, 2026 | RBC Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View JNJ Stock Page
Frequently Asked Questions
What does the Outperform rating mean for JNJ?
A rating of Outperform from Leerink Partners reflects the analyst's outlook on Johnson & Johnson (NYSE:JNJ). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the JNJ forecast page.
